BioWorld recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions.

America’s pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 marks the 21st anniversary of “World AIDS Day” a global awareness campaign that originated at the 1988 World [...]

As part of the ongoing collaborative efforts to improve health and save lives in the developing world, Canada’s Research-Based Pharmaceutical Companies (Rx&D) supports the actions of its member companies to provide an HIV/AIDS medicine to Rwanda under Canada’s Access to Medicines Regime (CAMR).

The first of its kind in Israel, a new clinic at Hadassah Ein Kerem Hospital in Jerusalem will allow persons who are carriers of viral diseases (Hepatitis C, HIV) to have healthy children using an innovative treatment: washing the sperm.

A group including leading academic and industry scientists has issued a challenge to researchers in the field of HIV/AIDS: find a way to effectively purge latent HIV infection and eliminate the need for chronic, suppressive therapy to control this disease. “The Challenge of a Cure for HIV Infection,” published in the March 6 issue of [...]